Vaxart
VXRT
VXRT was delisted on the 7th of July, 2025.
34 hedge funds and large institutions have $3.81M invested in Vaxart in 2017 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 5 closing their positions.
13% more repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 8
0% more funds holding
Funds holding: 34 → 34 (0)
0% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 5
0.7% less ownership
Funds ownership: 2.28% → 1.58% (-0.7%)
43% less capital invested
Capital invested by funds: $6.64M → $3.81M (-$2.83M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$96.2K |
| 2 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$19.6K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$18.3K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$17.2K |
| 5 |
JP Morgan Chase
New York
|
+$15.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
-$944K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$672K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$140K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$131K |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$92.9K |
VXRT Hedge Fund Activity: Q4 2017 in Review
34 of the 4,419 institutional investors tracked by Wall St. Rank reported a position in Vaxart (VXRT) for Q4 2017, worth a combined $3.81M — down 43% from $6.64M a quarter earlier.
Fund positioning in VXRT was balanced in Q4 2017: 5 funds opened new positions, 5 closed out, 9 added to existing stakes and 8 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $96.2K. The largest seller was Armistice Capital, exiting entirely with an estimated $944K sold.
- 34 institutional investors held Vaxart (VXRT) as of Q4 2017, unchanged from Q3 2017.
- Funds reported $3.81M of Vaxart stock for Q4 2017, down 43% quarter-over-quarter.
- 5 funds opened new Vaxart positions in Q4 2017 and 5 closed out, a net change of 0 holders.
- The largest Vaxart buyer in Q4 2017 was Renaissance Technologies, an estimated $96.2K added.
- The largest Vaxart seller in Q4 2017 was Armistice Capital, an estimated $944K sold.
Based on aggregated 13F filings for Q4 2017.